Desk›Financial Services› Prism Medico and Pharmacy Ltd
Prism Medico and Pharmacy Ltd
BSE 512217 · NSE PRISMMEDI · ISIN INE730E01016 · Group X · Active
Financial Services › Financial Services › Finance › Non Banking Financial Company (NBFC)
₹29.56
+4.38%
BSE close, 28 August 2026
₹40.09 cr
1.4 cr shares · Micro cap
₹29.66 cr
as published
-101.9× · 2.66×
EPS ₹-0.29 · BV ₹11.11
2.44 / 0.32
₹ cr, as filed
16
2 selected · 12%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -14.3% |
|---|---|
| Against 52-week low | +90.6% |
| Day change | +4.38% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.29 |
|---|---|
| Price / earnings | -101.93× |
| Price / book | 2.66× |
| Book value — derived, price ÷ P/B | ₹11.11 |
| Return on equity | -2.64% |
| Operating margin | — |
| Net margin | — |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -2.61%
- ROE as published
- -2.64%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | — | -0.06 | 0.04 | — | — |
| Mar-26 · Q | 0.28 | -0.24 | -0.30 | -43.42% | -85.77% |
| FY25-26 | 2.44 | 0.32 | 0.53 | 17.89% | 13.02% |
Quarter on quarter
- Net profit, quarter on quarter
- +75.0%
Disclosure profile 16 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Selected sub-total | 2 |
| Procedural | |
| General | 4 |
| AGM / EGM | 2 |
| Board Meeting | 2 |
| Other Update | 2 |
| Annual Report | 1 |
| Book Closure | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 14 |
| Total | 16 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
16 filings · 2 selected · busiest 2026-08-24
Filing rhythm · the twelve most recent
2026-08-192026-10-05
SelectedProcedural
Filings
16 in the window · 4 earlier on record
-
5 October 2026 ·
Compliance-57 (5) : intimation after the end of quarter
Dear Sir/ Madam Pursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), please find the ....
Others / 57 (5) : intimation after the end of quarter View filing →
-
30 September 2026 ·
Compliance-57 (4) : Prior intimation to the beginning of the quarter
Dear Sir/ Madam, Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations, 2015 (LODR), please find the ....
Others / 57 (4) : Prior intimation to the beginning of the quarter View filing →
-
30 September 2026 ·
Closure of Trading Window
Dear Sir/Madam, Pursuant to Code of Conduct to regulate, Monitor and report Trading by Insiders ('Code') and applicable SEBI Regulations, please find the attached intimation by the ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Dear Sir/ Madam, Pursuant to Provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and provisions of Regulation ....
AGM/EGM / AGM View filing →
-
26 August 2026 ·
Reg. 34 (1) Annual Report.
Dear Sir/Madam, Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith ....
Others / Reg. 34 (1) Annual Report View filing →
-
24 August 2026 ·
Intimation Of Record Date.
Dear Sir/ Madam, Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ....
Corp. Action / Record Date View filing →
-
24 August 2026 ·
Intimation Of Book Closure.
Dear Sir/Madam, Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March, 2026. You are requested ....
Corp. Action / Book Closure View filing →
-
24 August 2026 ·
Annual Report For The Financial Year 2025-2026.
Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....
Company Update / General View filing →
-
24 August 2026 ·
Annual Report For The Financial Year 2025-2026.
Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....
Company Update / General View filing →
-
24 August 2026 ·
Notice Of 24Th Annual General Meeting.
Dear Sir/Madam, The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September, 2026 through VC/OAVM. The notice of the same is attached ....
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
1. Considered & approved: (i) Director's Report for the F.Y. ended March 31, 2026 (ii) notice of 24th AGM to be held on September 19, 2026 at 12:30 P.M. through VC/OAVM 2. Fixed date ....
Board Meeting / Outcome of Board Meeting View filing →
-
19 August 2026 ·
Board Meeting Intimation for Regulation 29(1) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Prism Medico And Pharmacy Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 ,inter alia, to consider and approve ? To consider and ....
Board Meeting / Board Meeting View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Prism Medico And Pharmacy Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....
Board Meeting / Board Meeting View filing →
-
30 July 2026 ·
Undertaking Of Functional Website.
Dear Sir/Madam, This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India ....
Company Update / General View filing →
-
21 July 2026 ·
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Please find the attache statements of investor complaints for the quarter ended 30th June, 2026. You are requested to kindly take the same on record and oblige. Thanking ....
Company Update / General View filing →
RSS feed for Prism Medico and Pharmacy Ltd · the 50 most recent filings